A REVIEW ON “NEW TREATMENT STRATEGIES FOR ALZHEIMER’S DISEASE AS NEURODEGENERATIVE DISEASE AND ITS RISK FACTOR CAUSE, SYMPTOMS, AND TREATMENT AT WORLDWIDE”

ABSTRACTAlzheimer’s disease (AD) is a dynamic and irreversible neurodegenerative illness and relates to the most widely recognized reason for dementiaaround the world. AD is a dynamic and lethal cerebrum ailment. Alzheimer’s obliterates mind cells, bringing on memory issue or misfortune and issueswith speculation and conduct sufficiently serious to influence work, long lasting leisure activities or social life. Alzheimer’s illness is quickly becomingworldwide, but there is no cure for it. Now, accessible medications just give symptomatic help and do not mediate in infection prepare adequatelyenough to avert or cure it. Various late studies have reported that working memory does not appear to demonstrate regular age-related deficienciesin solid more established grown-ups when enthusiastic data are included. Indeed, contingent upon the capacity included, patients might demonstratean enthusiastic advantage in their working memory execution. Moreover, this advantage is not generally obviously one-sided (e.g., toward negativeor positive data). We decipher this intricate example of results as an outcome of the cooperation between numerous components including theseriousness of AD, the nature of emotional jolts, and sort of working memory errand. Clinical advantages of the accessible pharmacological treatmentfor AD with antidementia drugs (to be specific cholinesterase inhibitors and Memantine) are obvious. In an unexpected way, learns about the transientcapacity to encode and effectively control enthusiastic data in dementia of Alzheimer’s sort are few and have yielded blended results.Keywords: Alzheimer’s disease, Risk factor for Alzheimer’s disease, Diagnosis, Classification of Anti-Alzheimer’s drug.